David Einhorn - DME Capital Management
Holding/activity history for Lakefront Biotherapeutics NV (LKFT)
← All LKFT superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 482,746 | 0.45 | $30.00 | $14,482,380 | SEC | ||
| 2025 Q4 | 482,746 | 0.55 | $32.70 | $15,785,794 | SEC | ||
| 2025 Q3 | 482,746 | 0.66 | $34.64 | $16,722,321 | SEC | ||
| 2025 Q2 | 482,746 | 0.58 | $27.99 | $13,512,060 | SEC | ||
| 2025 Q1 | 482,746 | 0.61 | Add 0.71% | <0.01 | $22.36–29.70 · VW $25.32i | $12,126,580 | SEC |
| 2024 Q4 | 479,363 | 0.68 | $27.50 | $13,182,483 | SEC | ||
| 2024 Q3 | 479,363 | 0.57 | Add 104.13% | 0.29 | $24.16–31.06 · VW $27.80i | $13,800,860 | SEC |
| 2024 Q2 | 234,828 | 0.28 | Add 46.93% | 0.09 | $24.78–32.57 · VW $28.22i | $5,819,038 | SEC |
| 2024 Q1 | 159,828 | 0.24 | Reduce 1.69% | <0.01 | $31.88–42.46 · VW $36.66i | $5,146,462 | SEC |
| 2023 Q4 | 162,578 | 0.32 | Add 3.96% | 0.01 | $31.86–41.05 · VW $35.94i | $6,608,796 | SEC |
| 2023 Q3 | 156,378 | 0.31 | Add 4.14% | 0.01 | $34.01–44.25 · VW $39.42i | $5,402,861 | SEC |
| 2023 Q2 | 150,168 | 0.29 | Reduce 0.79% | <0.01 | $37.20–45.21 · VW $40.94i | $6,105,832 | SEC |
| 2023 Q1 | 151,368 | 0.32 | Reduce 2.57% | 0.01 | $36.17–48.07 · VW $39.44i | $5,848,859 | SEC |
| 2022 Q4 | 155,358 | 0.48 | Add 6.13% | 0.03 | $37.24–46.97 · VW $42.59i | $6,894,789 | SEC |
| 2022 Q3 | 146,388 | 0.44 | $42.64 | $6,242,000 | SEC | ||
| 2022 Q2 | 146,388 | 0.64 | Reduce 8.62% | 0.05 | $51.93–72.11 · VW $58.96i | $8,169,000 | SEC |
| 2022 Q1 | 160,200 | 0.63 | Reduce 13.41% | 0.08 | $50.32–69.50 · VW $63.13i | $9,936,000 | SEC |
| 2021 Q4 | 185,000 | 0.59 | Buy | 0.59 | $46.41–57.63 · VW $52.04i | $10,199,000 | SEC |
Price snapshot:
Current price$29.80
Avg. buy price$36.23
+/- since buy-17.75%
52-week low$26.42
52-week high$37.78